Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 29%
Buy 57%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

UnitedHealth Group is positioned as a leader in medical insurance with strong employer-sponsored and government-backed plans, as well as an expanding healthcare services division. Despite some challenges in their Medicare and Medicaid sectors, the company has exceeded expectations and is focused on improving margins through AI technology and strategic acquisitions. With potential for continued growth and a promising outlook, UnitedHealth Group offers potential for strong returns but also faces risks related to managing costs and government regulations.

Bears say

UnitedHealth Group is showing strong financial performance in the near term, with positive results and raised guidance for the 2026 fiscal year. However, there are concerns regarding rising healthcare costs, particularly in the commercial segment, and regulatory and reimbursement risks in the highly regulated industry. Additionally, investigations and lawsuits could also pose a threat to the company's reputation and financials. Despite these risks, UnitedHealth Group is well-positioned with its massive scale and diversified portfolio of healthcare services.

UnitedHealth Group (UNH) has been analyzed by 21 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 21 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $454.76, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $454.76, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.